新冠疫情期间美国急诊玻璃体视网膜手术频率变化
研究纳入全美17家机构的玻璃体视网膜执业数据,分析2019年1月1日至2020年5月31日11个计费CPT代码的周频率。结果显示,新冠疫情高峰期玻璃体视网膜手术频率较2019年显著下降,且下降幅度与地区、机构类型、州居家令无关。
要点
- 疫情期间玻璃体视网膜手术频率大幅下降,最高降幅达84.3%
- 下降幅度与地区、机构类型、州居家令均无关
- 尽管AAO建议继续急诊手术,实际开展频率仍显著减少
核心结论
- 尽管AAO建议继续开展急诊玻璃体视网膜手术,全美此类手术频率仍大幅下降,且可能持续至疫情初期指数增长阶段之后。
- 手术频率下降与地区、机构类型及州级居家令无关。
- 尚不清楚若无AAO建议手术频率会下降多少,以及该下降与结局的关联。
研究设计与样本
- 多中心横断面研究,纳入全美17家机构的玻璃体视网膜执业数据。
- 获取2019年1月1日至2020年5月31日各周11个计费CPT代码的频率。
- 按地区、机构类型及州居家令日期分类。
主要发现
- 玻璃体腔注射在2020年3月30日至5月2日每周减少,4月6日至12日最大降幅38.6%(95%CI -259至-69次注射;P=.002)。
- 激光/冷冻治疗最大降幅79.6%(95%CI -6.8至-3.3次操作;P<.001),视网膜脱离修复最大降幅59.4%(95%CI -2.7至-1.4次修复;P<.001),其他玻璃体切除最大降幅84.3%(95%CI -3.3至-1.8次;P<.001)。
- 未发现地区、机构类型或州居家令调整后的差异。
临床怎么用
- 疫情期间应优先保障高急症玻璃体视网膜疾病的处理可及性,直至明确手术量下降的原因。
- 关注急诊玻璃体视网膜手术量下降对患者结局的潜在影响。
局限性
- 为观察性横断面研究,无法确定手术量下降与患者结局的因果关系。
- 无法获知若无AAO建议手术量会如何变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The American Academy of Ophthalmology (AAO) indicated that urgent or emergent vitreoretinal surgical procedures should continue during the coronavirus disease 2019 (COVID-19) pandemic. Although decreases in the frequency of critical procedures have been reported outside the field of ophthalmology, analyses are limited by volume, geography, and time. OBJECTIVE: To evaluate whether the frequency of ophthalmic surgical procedures deemed urgent or emergent by the AAO changed across the United States during the COVID-19 pandemic. DESIGN, SETTING, AND PARTICIPANTS: Vitreoretinal practices from 17 institutions throughout the US participated in this multicenter cross-sectional study. The frequency of 11 billed vitreoretinal Current Procedural Terminology (CPT) codes across respective weeks was obtained from each practice between January 1, 2019, and May 31, 2020. Data were clustered into intravitreal injections (code 67028), lasers and cryotherapy (codes 67141, 67145, and 67228), retinal detachment (RD) repairs (codes 67107, 67108, 67110, and 67113), and other vitrectomies (codes 67036, 67039, and 67040). Institutions were categorized by region (Northeast, Midwest, South, and West Coast), practice setting (academic [tax-exempt] or private [non-tax-exempt]), and date of respective statewide stay-at-home orders. MAIN OUTCOMES AND MEASURES: Nationwide changes in the frequency of billing for urgent or emergent vitreoretinal surgical procedures during the COVID-19 pandemic. RESULTS: A total of 526 536 CPT codes were ascertained: 483 313 injections, 19 257 lasers or cryotherapy, 14 949 RD repairs, and 9017 other vitrectomies. Relative to 2019, a weekly institutional decrease in injections was observed from March 30 to May 2, 2020, with a maximal 38.6% decrease (from a mean [SD] of 437.8 [436.3] to 273.8 [269.0] injections) from April 6 to 12, 2020 (95% CI, -259 to -69 injections; P = .002). A weekly decrease was also identified that spanned a longer interval, at least until study conclusion (March 16 to May 31, 2020), for lasers and cryotherapy, with a maximal 79.6% decrease (from a mean [SD] of 6.6 [7.7] to 1.5 [2.0] procedures) from April 6 to 12, 2020 (95% CI, -6.8 to -3.3 procedures; P < .001), for RD repairs, with a maximal 59.4% decrease (from a mean [SD] of 3.5 [4.0] to 1.6 [2.2] repairs) from April 13 to 19, 2020 (95% CI, -2.7 to -1.4 repairs; P < .001), and for other vitrectomies, with a maximal 84.3% decrease (from a mean [SD] of 3.0 [3.1] to 0.4 [0.8] other vitrectomies) from April 6 to 12, 2020 (95% CI, -3.3 to -1.8 other vitrectomies; P < .001). No differences were identified by region, setting, or state-level stay-at-home order adjustment. CONCLUSIONS AND RELEVANCE: Although the AAO endorsed the continued performance of urgent or emergent vitreoretinal surgical procedures, the frequency of such procedures throughout the country experienced a substantial decrease that may persist after the COVID-19 pandemic's initial exponential growth phase. This decrease appears independent of region, setting, and state-level stay-at-home orders. It is unknown to what extent vitreoretinal intervention would have decreased without AAO recommendations, and how the decrease is associated with outcomes. Although safety is paramount during the COVID-19 pandemic, practices should consider prioritizing availability for managing high-acuity conditions until underlying reasons for the reduction are fully appreciated.
引用
- Breazzano MP, Nair AA, Arevalo JF, et al. Frequency of Urgent or Emergent Vitreoretinal Surgical Procedures in the United States During the COVID-19 Pandemic. JAMA Ophthalmol. 2021. PMID: 33662093. doi:10.1001/jamaophthalmol.2021.0036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。